lioresal 25 mg
novartis pharma gmbh - germania - baclofenum - compr. - 25mg - miorelaxante centrale alte miorelaxante cu actiune centrala
zyvoxid 2mg/ml
pfizer europe ma eeig - linezolidum - sol. perf. - 2mg/ml - alte antibacteriene alte antibacteriene
pneumolid 2 mg/ml
synthon bv - olanda - linezolidum - sol. perf. - 2mg/ml - alte antibacteriene alte antibacteriene
sodium lactat ringer 1,55 g+3,0 g+0,15 g+0,1 g soluţie perfuzabilă
cisen pharmaceutical co., ltd. - combinaţie - soluţie perfuzabilă - 1,55 g+3,0 g+0,15 g+0,1 g
sodium lactat ringer 1,55 g+3,0 g+0,15 g+0,1 g soluţie perfuzabilă
cisen pharmaceutical co., ltd. - combinaţie - soluţie perfuzabilă - 1,55 g+3,0 g+0,15 g+0,1 g
fingolimod zentiva 0,5 mg
zentiva s.a. - romania - fingolimodum - caps. - 0,5mg - imunosupresoare imunosupresoare selective
fingolimod tiefenbacher 0,5 mg
delorbis pharmaceuticals ltd. - cipru - fingolimodum - caps. - 0,5mg - imunosupresoare imunosupresoare selective
inzolfi 0,5 mg
novartis pharma gmbh - germania - fingolimodum - caps. - 0,5mg - imunosupresoare imunosupresoare selective
aspaveli
swedish orphan biovitrum ab (publ) - pegcetacoplan - hemoglobinurie, paroxismal - imunosupresoare - aspaveli is indicated in the treatment of adult patients with paroxysmal nocturnal haemoglobinuria (pnh) who are anaemic after treatment with a c5 inhibitor for at least 3 months.
fingolimod richter 0,5 mg
synthon hispania s.l. - spania - fingolimodum - caps. - 0,5mg - imunosupresoare imunosupresoare selective